Statements (10)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Denali_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
DNL201
|
| gptkbp:intendedUse |
gptkb:Parkinson's_disease
|
| gptkbp:mechanismOfAction |
LRRK2 inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:bfsParent |
gptkb:LRRK2
|
| gptkbp:bfsLayer |
7
|